BSTG Insider Trading Activity and SEC Form 4 Filings
BSTG insider trading summary
No open-market insider purchases or sales of Biostage, Inc. (BSTG) have been reported on SEC Form 4 in the past 12 months.
Latest BSTG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 6, 2023 | DST Capital LLC | 10% Owner | Buy | $375K (62,500 @ $6.00) |
| Dec 12, 2022 | Junli He | Insider | Sell | $922 (135 @ $6.83) |
| Dec 7, 2022 | Hong Yu | President | Sell | $600K (83,676 @ $7.17) |
| Dec 7, 2022 | Jing Chen | Insider | Sell | $348K (48,532 @ $7.17) |
| Dec 7, 2022 | DST Capital LLC | Insider | Sell | $14K (1,952 @ $7.17) |
| May 12, 2022 | James E. Shmerling | Director | Buy | $100K (16,892 @ $5.92) |
| May 12, 2022 | DST Capital LLC | 10% Owner | Buy | $49K (8,277 @ $5.92) |
| May 12, 2022 | David Green | Interim CEO | Buy | $375K (63,345 @ $5.92) |
| Nov 26, 2021 | David Green | Interim CEO | Buy | $250K (72,464 @ $3.45) |
| Sep 1, 2021 | DST Capital LLC | 10% Owner | Buy | $1.0M (500,000 @ $2.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.